OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase II study of radiopeptide 177Lu-octreotate and capecitabine therapy of progressive disseminated neuroendocrine tumours

HTML

Year: 2010
Type: article
Study design: Clinical Trial
Source: European Journal of Nuclear Medicine and Molecular Imaging
DOI: 10.1007/s00259-010-1631-x
Authors: Phillip G. Claringbold, Paul A. Brayshaw, Richard A. Price, J. Harvey Turner
Institutions: Fremantle Hospital, The University of Western Australia
Language: English

Topic: Neuroendocrine Tumor Research Advances
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: 177Lu-octreotate, capecitabine, neuroendocrine tumors, metastatic neuroendocrine tumors, peptide receptor radionuclide therapy, radiosensitizing chemotherapy, combination therapy, objective response rate, progression-free survival, overall survival, myelosuppression, nephrotoxicity, radiation dosimetry
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1988986189
FWCI: 4.218
Cites: 39
Cited by: 217
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms